The p53-PUMA axis suppresses iPSC generation

Nature Communications

Volumn 4, Issue , 2013, Pages

  Li, Yanxin ^a   Feng, Haizhong ^b   Gu, Haihui ^a,c   Lewis, Dale W ^d   Yuan, Youzhong ^e   Zhang, Lei ^a   Yu, Hui ^e   Zhang, Peng ^e   Cheng, Haizi ^e   Miao, Weimin ^a   Yuan, Weiping ^a   Cheng, Shi Yuan ^f   Gollin, Susanne M ^d   Cheng, Tao ^a,e  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^f Center for Behavioral Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P21; PROTEIN P53; PUMA PROTEIN;

APOPTOSIS; BIOCHEMISTRY; CHROMOSOME; CYTOLOGY; DISEASE TREATMENT; DNA; GENE EXPRESSION; MEDICINE; PHYSIOLOGY; RODENT;

ANAPHASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; COLONY FORMATION; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; GENOMIC INSTABILITY; GENOTYPE; INTERPHASE; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN DEPLETION; SURVIVAL RATE;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BIOLOGICAL MARKERS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINEAGE; CHROMOSOME ABERRATIONS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; EMBRYO, MAMMALIAN; FEMALE; FIBROBLASTS; GENE DELETION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INDUCED PLURIPOTENT STEM CELLS; MALE; MICE; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84880837087     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3174     Document Type: Article

References (48)

1. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
2. Izpisua Belmonte, J. C., Ellis, J., Hochedlinger, K. & Yamanaka, S. Induced pluripotent stem cells and reprogramming: seeing the science through the hype. Nat. Rev. Genet. 10, 878-883 (2009).
3. Yamanaka, S. A fresh look at iPS cells. Cell 137, 13-17 (2009).
4. Park, I. H. et al. Disease-specific induced pluripotent stem cells. Cell 134, 877-886 (2008).
5. Jaenisch, R. & Young, R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132, 567-582 (2008).
6. Yamanaka, S. & Blau, H. M. Nuclear reprogramming to a pluripotent state by three approaches. Nature 465, 704-712 (2010).
7. Hanna, J. et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462, 595-601 (2009).
8. Smith, Z. D., Nachman, I., Regev, A. & Meissner, A. Dynamic single-cell imaging of direct reprogramming reveals an early specifying event. Nat. Biotechnol. 28, 521-526 (2010).
9. Laurent, L. C. et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8, 106-118 (2011).
10. Blasco, M. A., Serrano, M. & Fernandez-Capetillo, O. Genomic instability in iPS: time for a break. EMBO J. 30, 991-993 (2011).
11. Hussein, S. M. et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471, 58-62 (2011).
12. Gore, A. et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63-67 (2011).
13. Young, M. A. et al. Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells. Cell Stem Cell 10, 570-582 (2012).
14. Quinlan, A. R. et al. Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming. Cell Stem Cell 9, 366-373 (2011).
15. Mekhoubad, S. et al. Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell 10, 595-609 (2012).
16. Vousden, K. H. & Prives, C. Blinded by the light: the growing complexity of p53. Cell 137, 413-431 (2009).
17. Vogelstein, B., Lane, D. & Levine, A. J. Surfing the p53 network. Nature 408, 307-310 (2000).
18. Carr, A. M. Cell cycle. Piecing together the p53 puzzle. Science 287, 1765-1766 (2000).
19. Nakano, K. & Vousden, K. H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7, 683-694 (2001).
20. Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W. & Vogelstein, B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell 7, 673-682 (2001).
21. Kawamura, T. et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460, 1140-1144 (2009).
22. Hong, H. et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460, 1132-1135 (2009).
23. Zhao, Y. et al. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 3, 475-479 (2008).
24. Krizhanovsky, V. & Lowe, S. W. Stem cells: the promises and perils of p53. Nature 460, 1085-1086 (2009).
25. Marion, R. M. et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460, 1149-1153 (2009).
26. Utikal, J. et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460, 1145-1148 (2009).
27. Li, H. et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460, 1136-1139 (2009).
28. Yu, J. & Zhang, L. PUMA, a potent killer with or without p53. Oncogene 27(Suppl 1), S71-S83 (2008).
29. Labi, V. et al. Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation. Gene Dev. 24, 1602-1607 (2010).
30. Michalak, E. M. et al. Apoptosis-promoted tumorigenesis: gamma-irradiationinduced thymic lymphomagenesis requires Puma-driven leukocyte death. Gene Dev. 24, 1608-1613 (2010).
31. Yu, H. et al. Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose gamma-irradiation. Blood 115, 3472-3480 (2010).
32. Shao, L. et al. Deletion of proapoptotic Puma selectively protects hematopoietic stem and progenitor cells against high-dose radiation. Blood 115, 4707-4714 (2010).
33. Qiu, W. et al. PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell 2, 576-583 (2008).
34. Jeffers, J. R. et al. Puma is an essential mediator of p53-dependent and - independent apoptotic pathways. Cancer Cell 4, 321-328 (2003).
35. Villunger, A. et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302, 1036-1038 (2003).
36. Takahashi, K., Okita, K., Nakagawa, M. & Yamanaka, S. Induction of pluripotent stem cells from fibroblast cultures. Nat. Protoc. 2, 3081-3089 (2007).
37. Vassilev, L. T. et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303, 844-848 (2004).
38. Leibowitz, B. J. et al. Uncoupling p53 functions in radiation-induced intestinal damage via PUMA and p21. Mol. Cancer Res. 9, 616-625 (2011).
39. Cross, S. M. et al. A p53-dependent mouse spindle checkpoint. Science 267, 1353-1356 (1995).
40. Ermis, A. et al. Proliferation enhancement by spontaneous multiplication of chromosome 7 in rheumatic synovial cells in vitro. Hum. Genet. 96, 651-654 (1995).
41. Hoffelder, D. R. et al. Resolution of anaphase bridges in cancer cells. Chromosoma 112, 389-397 (2004).
42. Daley, G. Q. Common themes of dedifferentiation in somatic cell reprogramming and cancer. Cold Spring Harb. Symp. Quant. Biol. 73, 171-174 (2008).
43. Qiu, W. et al. PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice. Hepatology 54, 1249-1258 (2011).
44. Shen, H. et al. Bid is a positive regulator for donor-derived lymphoid cell regeneration in gamma-irradiated recipients. Exp. Hematol. 39, 947-957 e941 (2011).
45. Liu, G. et al. Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nat. Genet. 36, 63-68 (2004).
46. Michalak, E. M., Villunger, A., Adams, J. M. & Strasser, A. In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute. Cell Death Differ. 15, 1019-1029 (2008).
47. Qiu, W., Carson-Walter, E. B., Kuan, S. F., Zhang, L. & Yu, J. PUMA suppresses intestinal tumorigenesis in mice. Cancer Res. 69, 4999-5006 (2009).
48. Baumgartner, F. & Villunger, A. Apoptosis: a barrier against cancer no more? Hepatology 54, 1121-1124 (2011).